INC Reseach Expands CNS Team with Warren Prosser
13 August 2008
INC Research, a therapeutically-focused contract research organization (CRO) with a process for delivering reliable results, today announced the appointment of Warren A. Prosser, MBA, CCRA as the vice president, Clinical Operations for Global Neurology. Prosser will lead INC Research’s neurology teams on Phase I-III trials, and provide strategic and developmental consultation to pharmaceutical customers within its central nervous system (CNS) division.
Prosser has 18 years experience designing, implementing, monitoring, and managing clinical trials in a variety of therapeutic areas including neurology, cardiovascular and metabolic diseases. His knowledge in CRO, pharmaceutical and academic settings gives him a broad perspective in conducting successful Phase I-III clinical trials on a global basis.
“Warren is a critical addition to our CNS team as we continue to grow strategically,” said Michael Gibertini, executive vice president CNS, INC Research. “He brings tremendous talent and breadth of experience across many areas of drug development, and has built a fine reputation in the industry. This appointment underscores our commitment to exceeding customer expectations with outsourced clinical trials services delivered through our trusted process.”
Most recently, Prosser held the senior director, Clinical Operations position at Arena Pharmaceuticals where he provided oversight for all clinical trials conducted within five clinical development programs. During his tenure, he co-authored and presented numerous posters and papers based on his work with obesity and sleep disorders, as well as industry issues such as dose selection, design of Phase III trials and advanced technology to enhance data quality. Prosser also held senior and associate management positions at Dura Pharmaceuticals, PPD Pharmaco and Duke University Medical Center.
“My experience has allowed me to view the drug development process from multiple perspectives, which has been invaluable,” said Prosser. “INC Research gives me the opportunity to apply my knowledge and therapeutic foresight to the clinical trials process.”
INC Research is a recognized leader in the field of CNS conducting hundreds of global trials focused on pain, neurology and psychiatry over the past 20 years. Trials have involved more than 70,000 patients at more than 6,600 sites worldwide.
